10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
GILEAD SCIENCES, INC. | |||
Ticker: GILD Fiscal Year: 2014 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 25, 2015) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Net Cash Provided by (Used in) Operating Activities [Abstract] | |||
| Net income | $ 12,059 | 3,057 | 2,574 |
| Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities [Abstract] | |||
| Depreciation expense | 125 | 103 | 83 |
| Amortization expense | 925 | 242 | 195 |
| Stock-based compensation expense | 360 | 252 | 209 |
| Excess tax benefits from stock-based compensation | (482) | (279) | (114) |
| Tax benefits from exercise and vesting of stock-based awards | 484 | 285 | 113 |
| Deferred income taxes | (236) | (98) | (39) |
| Change in fair value of contingent consideration | 22 | 59 | 69 |
| Other | 79 | 46 | (3) |
| Changes in Operating Assets and Liabilities [Abstract] | |||
| Accounts receivable, net | (2,578) | (315) | 198 |
| Inventories | 143 | (343) | (350) |
| Prepaid expenses and other assets | (371) | (170) | (129) |
| Accounts payable | (289) | (98) | 117 |
| Income taxes payable | 533 | 30 | (68) |
| Accrued liabilities | 2,013 | 312 | 317 |
| Deferred revenues | 31 | 22 | 23 |
| Net cash provided by operating activities | 12,818 | 3,105 | 3,195 |
| Net Cash Provided by (Used in) Investing Activities [Abstract] | |||
| Purchases of marketable securities | (2,107) | (257) | (1,245) |
| Proceeds from sales of marketable securities | 807 | 494 | 528 |
| Proceeds from maturities of marketable securities | 52 | 78 | 45 |
| Other investments | (18) | 0 | (25) |
| Acquisitions, net of cash acquired | 0 | (379) | (10,752) |
| Capital expenditures | (557) | (190) | (397) |
| Net cash used in investing activities | (1,823) | (254) | (11,846) |
| Net Cash Provided by (Used in) Financing Activities [Abstract] | |||
| Proceeds from debt financing, net of issuance costs | 7,932 | 0 | 2,144 |
| Proceeds from convertible note hedges | 2,543 | 2,774 | 214 |
| Purchases of convertible note hedges | (26) | 0 | 0 |
| Proceeds from issuances of common stock | 331 | 313 | 466 |
| Repurchases of common stock | (5,349) | (582) | (667) |
| Repayments of debt and other long-term obligations | (4,779) | (4,440) | (1,839) |
| Payment to Settle Warrants Related to Convertible Notes | (4,093) | (1,040) | 0 |
| Excess tax benefits from stock-based compensation | 482 | 279 | 114 |
| Payment of contingent consideration | (101) | 0 | 0 |
| Contributions from noncontrolling interest | 35 | 152 | 131 |
| Net cash provided by (used in) financing activities | (3,025) | (2,544) | 563 |
| Effect of exchange rate changes on cash and cash equivalents | (56) | 2 | 8 |
| Net change in cash and cash equivalents | 7,914 | 309 | (8,080) |
| Cash and cash equivalents at beginning of period | 2,113 | 1,804 | |
| Cash and cash equivalents at end of period | 10,027 | 2,113 | 1,804 |
| Supplemental Cash Flow Information [Abstract] | |||
| Interest Paid, Net of Amount Capitalized | 330 | 238 | 249 |
| Income taxes paid | 2,060 | 1,051 | 1,101 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2014 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |